[1] S. Freiberg and X. X. Zhu, “Polymer microspheres for controlled drug release”, International Journal of Pharmaceutics, Vol. 282, No. 1-2, 2004, pp.1-18. Udoi:10.1016/j.ijpharm.2004.04.013
[2] R.H. Qin, F.S. Li, M.Y. Chen and W. Jiang, “Preparation of chitosan–ethylene diaminetetraacetate-enwrapped magnetic CoFe2O4 nanoparticles via zero-length emulsion crosslinking method”. Applied Surface Science, Vol. 256, No.1, 2009, pp.27-32.
[3] A. R. Dudhani and S.L.Kosaraju. “Bioadhesive chitosan nanoparticles: Preparation and characterization”, Carbohydrate Polymers, Vol. 81, No. 2, 2010, pp. 243-251. Udoi:10.1016/j.carbpol.2010.02.026
[4] S.A. Agnihotri and T.M. Aminabhavi, “Controlled release of clozapine through chitosan microparticles prepared by a novel method”, Journal of Controlled Release, Vol. 96, No. 2, 2004, pp. 245-259. Udoi:10.1016/j.jconrel.2004.01.025
[5] D. Chiou and T.A.G. Langrish, “Development and characterisation of novel nutraceuticals with spray drying technology”, Journal of Food Engineering, Vol. 82, No. 1, 2007, pp 84-91. Udoi:10.1016/j.jfoodeng.2007.01.021
[6] L. Ochiuz and J.E. Peris, “Preparation and Characterisation of Alendronate-Loaded Chitosan Microparticles Obtained Through the Spray Drying Technique”, Medicinal Chemistry, Vol. 5, No. 2, 2009, pp. 191-196(6).
[7] P. Tewa-Tagne, S. Brian?on and H. Fessi, “Preparation of redispersible dry nanocapsules by means of spray-drying: Development and characterization”, European Journal of Pharmaceutical Sciences, Vol. 30, No. 2, 2007, pp. 124- 135. Udoi:10.1016/j.ejps.2006.10.006
[8] K. Vimala, M. M. Yallapu, K. Varaprasad, N. N. Reddy, S. Ravindra, N. S. Naidu, K. M. Raju, “Fabrication of Curcumin Encapsulated Chitosan-PVA Silver Nanocomposite Films for Improved Antimicrobial Activity”, Journal of Biomaterials and Nanobiotechnology, Vol.2, No.1, 2011, PP. 55-64. Udoi: 10.4236/jbnb.2011.21008
[9] H. Li, C.R. Zhou, J.H. Tian and J.H. Rong, “Preparation and Characterization of Homogeneous Hydroxyapatite/Chitosan Composite Scaffolds via In-Situ Hydration”, Journal of Biomaterials and Nanobiotechnology, Vol.1, No.1, 2010, pp.42-49. doi:10.4236/jbnb.2010.11006
[10] Y. Murata, D. Hirai, K. Kofuji, E. Miyamoto and S. Kawashima, “Properties of an Alginate Gel Bead Containing a Chitosan-Drug Salt”, Biological & Pharmaceutical Bulletin, Vol. 27, No. 3, 2004, pp. 440-442. Udoi:10.1248/bpb.27.440
[11] P. He, S.S. Davis and L. Illum,”Chitosan microspheres prepared by spray drying”, International Journal of Pharmaceutics, Vol. 187, No.1, 1999, pp. 53-65. Udoi:10.1016/S0378-5173(99)00125-8
[12] P. Giunchedi, C. Juliano, E. Gavini, M. Cossu and M. Sorrenti, “Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres”, European Journal of Pharmaceutics and Biopharmaceutics, Vol. 53, No. 2, 2002, pp.233-239. Udoi:10.1016/S0939-6411(01)00237-5
[13] D.O. Corrigan, A.M. Healy and O.I. Corrigan, “Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates”, European Journal of Pharmaceutics and Biopharmaceutics, Vol. 62, No.3, 2006, pp. 295-305. Udoi:10.1016/j.ejpb.2005.09.008
[14] A. Alhalaweh, S. Andersson and S.P. Velaga, “Preparation of zolmitriptan–chitosan microparticles by spray drying for nasal delivery”, European Journal of Pharmaceutical Sciences, Vol. 38, No. 3, 2009, pp. 206-214. Udoi:10.1016/j.ejps.2009.07.003
[15] J.P.Zhang, Q. Wang and A.Q. Wang, “In situ generation of sodium alginate/ hydroxyapatite nanocomposite beads as drug-controlled release matrices”, Acta Biomaterialia, Vol.6, No.2, 2010, pp. 445-454. Udoi:10.1016/j.actbio.2009.07.001
[16] M. D. Arco, E. Cebadera, S. Gutiérrez, C. Martín, M.J. Montero, V. Rives, J. Rocha and M.A. Sevilla, “Mg, Al layered double hydroxides with intercalated indomethacin: Synthesis, characterization, and pharmacological study”, Journal of Pharmaceutical Science, Vol. 93, No.6, 2004, pp. 1649-1658. Udoi: 10.1002/jps.20054
[17] Q. Wang, X.L. Xie, X.W. Zhang, J.P. Zhang and A.Q. Wang, “Preparation and swelling properties of pH sensitive composite hydrogel beads based on chitosan-g-poly (acrylic acid)/vermiculite and sodium alginate for diclofenac controlled release”, International Journal of Biological Macromolecules, Vol.46, No.3, 2010, pp. 356- 362. Udoi:10.1016/j.ijbiomac.2010.01.009
[18] M.P.S. Krekeler and S. Guggenheim, “Defects in microstructure in palygorskite–sepiolite minerals: A transmission electron microscopy (TEM) study”, Applied Clay Science, Vol. 39, No. 1-2, 2008, pp. 98-105. Udoi:10.1016/j.clay.2007.05.001
[19] M.J. Fernández-Hervás, M.A. Holgado, A. Fini and J.T. Fell, “In vitro evaluation of alginate beads of diclofenac salts”, International Journal of Pharmaceutics, Vol.163, No. 1-2, 1998, pp. 23-34. Udoi:10.1016/S0378-5173(97)00333-5
[20] A. Lamprecht, N. Ubrich, H. Yamamoto, U. Sch?fer, H. Takeuchi, P. Maincent, Y. Kawashima andC.M. Lehr, “Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease”, The Journal of Pharmacology and Experimental Therapeutics, Vol. 299, No. 2, pp.775-781.
[21] A. Lamprecht, U. Schafer and C.M. Lehr, “Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa”, Pharmaceutical Research, Vol.18, No. 6, pp.788-793. UDOI:10.1023/A:1011032328064
[22] R.R. Dubey and R.H. Parikh, “Studies of PLGA microspheres”, Pharmaceutical Technology Europe, Vol. 16, 2004, pp. 23-34.
[23] N. Gottlieb and C. Schwartzbach, “Development of an internal mixing two-fluid nozzle by systematic variation of internal parts”, ILASS conference, Nottingham, UK. 2004. UHttp://www.niro.com/niro/cmsresources.nsf/filenames/TFN_Niro_Ilass_2004_Final.pdf/$file/TFN_Niro_Ilass_2004_Final.pdf
[24] V.H. Kulkarni, P.V. Kulkarni and J. Keshavayya, “Glutaraldehyde- crosslinked chitosan beads for controlled release of diclofenac sodium”, Journal of Applied Polymer Science, Vol.103, No. 1, 2007, pp. 211-217. Udoi:10.1002/app.25161
[25] T. Iliescu, M. Baia and W. Kiefer, “FT-Raman, surface-enhanced Raman spectroscopy and theoretical investigations of diclofenac sodium”. Chemical Physics, Vol. 298, No. 1-3, 2004, pp.167-174. Udoi:10.1016/j.chemphys.2003.11.018
[26] F.L. Mi, C.Y. Kuan, S.S. Shyu, S.T. Lee and S.F. Chang, “The study of gelation kinetics and chain-relaxation properties of glutaraldehyde-cross-linked chitosan gel and their effects on microspheres preparation and drug release”, Carbohydrate Polymers, Vol.41, No.4, 2000, pp. 389-396.
[27] M. Gibaldi and S. Feldman, “Establishment of sink conditions in dissolution rate determinations-theoretical considerations and application to nondisintegrating dosage forms”, Journal of Pharmaceutical Sciences, Vol. 56, No.10, 1967, pp. 1238-1242. Udoi: 10.1002/jps.2600561005
[28] J.G. Wagner, “Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules”, Journal of Pharmaceutical Sciences, Vol.58, No. 10, 1969, pp. 1253-1257. Udoi: 10.1002/jps.2600581021
[29] T. Higuchi, “Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices”. Journal of Pharmaceutical Sciences, Vol. 52, No.12, 1963, pp.1145-1149. Udoi: 10.1002/jps.2600521210
[30] P.L. Ritger and N.A. Peppas, “A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs”. Journal of Controlled Release, Vol. 5, No 1, 1987, pp. 23-36.
[31] J. Siepmann and N.A. Peppas, “Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)”, Advanced Drug Delivery Reviews, Vol.48, No.2-3, 2001, pp.139-157.